Skip to main content

Holocene Advisors, LP

SEC CIK
0001700574
Latest filing
Aug 14, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Holocene Advisors, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
9,205
Value
$720.5K
% of portfolio
<0.1%
Quarters held
4
Since Q3 2025
Holdings of HALO by Holocene Advisors, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,205$720.5K<0.1%00.0%UnchangedHolders
Q1 20269,205$594.9K<0.1%00.0%UnchangedHolders
Q4 20259,205$619.5K<0.1%−5,204−36.1%ReducedHolders
Q3 202514,409$1.06M<0.1%+14,409NewHolders